Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...
Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...
In particular, new FDA requirements around modifying IVDs could lead labs to push for IVD vendors to validate their tests ...
Beckman Coulter Life Sciences and Illumina announced the launch of the Illumina TruSight Oncology 500 DNA/ RNA assay on the ...
Brandon Couillard, an analyst from Wells Fargo, maintained the Hold rating on Danaher (DHR – Research Report). The associated price ...
Furthermore, Brennan was encouraged by the specific growth initiatives discussed for key players within the Dx segment like Cepheid and Beckman Coulter. Projections for Cepheid’s growth in the low ...
Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...
Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term ...
During the call, the company will discuss its financial performance, as well as future expectations. Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback